Home › Osteosarcoma › Ohio
Osteosarcoma clinical trials in Ohio
12 studies for Osteosarcoma are looking for participants at sites in Ohio.
Cities in Ohio
Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor
- Cincinnati Children's Hospital Medical Center, Cincinnati
RecruitingPhase 2
Ages 12 to 39 · All sexes · Updated Sep 29, 2026 · NCT04616560Domatinostat With Sirolimus for Relapsed, Refractory Sarcoma and Osteosarcoma
- Nationwide Children's Hospital, Columbus
RecruitingPhase 1/2
Ages 12 to 40 · All sexes · Updated Sep 3, 2026 · NCT07725380Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- Cincinnati Children's Hospital Medical Center, Cincinnati
RecruitingPhase 1/2
12 Months – 30 Years · All sexes · Updated Aug 25, 2026 · NCT04851119Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
- Children's Hospital Medical Center of Akron, Akron
- Cincinnati Children's Hospital Medical Center, Cincinnati
- Rainbow Babies and Childrens Hospital, Cleveland
- and 4 more
RecruitingPhase 3
Up to age 50 · All sexes · Updated Aug 25, 2026 · NCT05235165SPEARHEAD-3 Pediatric Study
- Cincinnati Children's Hospital Medical Center, Cincinnati
RecruitingPhase 1/2
Ages 2 to 21 · All sexes · Updated Aug 11, 2026 · NCT05642455Musculoskeletal Cancers Remote Monitoring and Care
- Case Comprehensive Cancer Center, Cleveland Clinic Foundation, Cleveland
Recruiting
Ages 18 and older · All sexes · Updated Aug 6, 2026 · NCT07129226Disulfiram With Copper Gluconate and Liposomal Doxorubicin in Treatment-Refractory Sarcomas
- Cleveland Clinic, Case Comprehensive Cancer Center, Cleveland
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 6, 2026 · NCT05210374NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)
- Cincinnati Children's Hospital Medical Center, Cincinnati
RecruitingPhase 1/2
Up to age 30 · All sexes · Updated Aug 3, 2026 · NCT06239272Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
- Children's Hospital Medical Center of Akron, Akron
- Cincinnati Children's Hospital Medical Center, Cincinnati
RecruitingObservational study
All ages · All sexes · Updated May 18, 2026 · NCT01790152A Study to Evaluate the Utilization of 3D Printed Models in Pre-Operative Planning
- The Ohio State University Wexner Medical Center, Columbus
Recruiting
Ages 13 and older · All sexes · Updated Feb 6, 2026 · NCT06387485A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
- Nationwide Children's Hospital, Columbus
RecruitingPhase 2
18 Months – 40 Years · All sexes · Updated Aug 12, 2025 · NCT05135975Study to Assess Safety and Efficacy of Vactosertib in Adolescents and Adults With Recurrent, Refractory or Progressive Osteosarcoma
- UH Rainbow Babies & Children's Hospital, Cleveland
RecruitingPhase 1/2
Ages 12 and older · All sexes · Updated Apr 10, 2025 · NCT05588648From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.